pubmed-article:15034031 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15034031 | lifeskim:mentions | umls-concept:C0014597 | lld:lifeskim |
pubmed-article:15034031 | lifeskim:mentions | umls-concept:C0111208 | lld:lifeskim |
pubmed-article:15034031 | lifeskim:mentions | umls-concept:C1332717 | lld:lifeskim |
pubmed-article:15034031 | lifeskim:mentions | umls-concept:C1706438 | lld:lifeskim |
pubmed-article:15034031 | lifeskim:mentions | umls-concept:C2698599 | lld:lifeskim |
pubmed-article:15034031 | lifeskim:mentions | umls-concept:C0039194 | lld:lifeskim |
pubmed-article:15034031 | lifeskim:mentions | umls-concept:C0022077 | lld:lifeskim |
pubmed-article:15034031 | lifeskim:mentions | umls-concept:C1155065 | lld:lifeskim |
pubmed-article:15034031 | lifeskim:mentions | umls-concept:C0085358 | lld:lifeskim |
pubmed-article:15034031 | lifeskim:mentions | umls-concept:C1171362 | lld:lifeskim |
pubmed-article:15034031 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:15034031 | lifeskim:mentions | umls-concept:C1413244 | lld:lifeskim |
pubmed-article:15034031 | lifeskim:mentions | umls-concept:C2698600 | lld:lifeskim |
pubmed-article:15034031 | lifeskim:mentions | umls-concept:C1515670 | lld:lifeskim |
pubmed-article:15034031 | lifeskim:mentions | umls-concept:C0031916 | lld:lifeskim |
pubmed-article:15034031 | lifeskim:mentions | umls-concept:C1947978 | lld:lifeskim |
pubmed-article:15034031 | lifeskim:mentions | umls-concept:C2348867 | lld:lifeskim |
pubmed-article:15034031 | lifeskim:mentions | umls-concept:C0301625 | lld:lifeskim |
pubmed-article:15034031 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:15034031 | pubmed:dateCreated | 2004-3-22 | lld:pubmed |
pubmed-article:15034031 | pubmed:abstractText | Pigment epithelial (PE) cells cultured from the eye possess the novel property of suppressing TCR-dependent activation of T cells in vitro. Iris PE (IPE) cells accomplish this suppression by a direct cell contact mechanism in which B7-2 expressed by the PE cells interacts with CTLA-4 on responding T cells. Because CTLA-4 expression is constitutively expressed on a very small proportion of naive splenic T cells and since exposure of splenic T cells to IPE leads to global T cell suppression, we have inquired into the mechanism by which suppression is achieved. Using splenic T cells and IPE from donor mice with disrupted genes for CD80 (B7-1), CD86 (B7-2), CTLA-4, and/or CD28, we report that B7-2(+) IPE in the presence of anti-CD3 supported selectively the activation of CTLA-4(+) CD8(+) T cells that express their own B7-2 and secrete enhanced amounts of active TGFbeta. By contrast, activation of CTLA-4-negative T cells, especially CD4(+) cells, in these cultures was profoundly suppressed. Because global suppression of T cell activation in these cultures was obtained only when both IPE and T cells possessed B7-2 genes and expressed the costimulators as surface molecules, we propose that T cells activated in the presence of parenchymal cells from the eye (an immune privileged site) express B7-2 in a manner that equips them to suppress bystander T cells. Thus, B7-2 expression on T cells participates in their eventual ability to function as regulators in vitro. | lld:pubmed |
pubmed-article:15034031 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15034031 | pubmed:language | eng | lld:pubmed |
pubmed-article:15034031 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15034031 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:15034031 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15034031 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15034031 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15034031 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15034031 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15034031 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15034031 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15034031 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15034031 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15034031 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15034031 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15034031 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15034031 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15034031 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15034031 | pubmed:month | Apr | lld:pubmed |
pubmed-article:15034031 | pubmed:issn | 0022-1767 | lld:pubmed |
pubmed-article:15034031 | pubmed:author | pubmed-author:StreileinJ... | lld:pubmed |
pubmed-article:15034031 | pubmed:author | pubmed-author:NgTat FongTF | lld:pubmed |
pubmed-article:15034031 | pubmed:author | pubmed-author:Schwartzkopff... | lld:pubmed |
pubmed-article:15034031 | pubmed:author | pubmed-author:SugitaSunaoS | lld:pubmed |
pubmed-article:15034031 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15034031 | pubmed:day | 1 | lld:pubmed |
pubmed-article:15034031 | pubmed:volume | 172 | lld:pubmed |
pubmed-article:15034031 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15034031 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15034031 | pubmed:pagination | 4184-94 | lld:pubmed |
pubmed-article:15034031 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:meshHeading | pubmed-meshheading:15034031... | lld:pubmed |
pubmed-article:15034031 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15034031 | pubmed:articleTitle | CTLA-4+CD8+ T cells that encounter B7-2+ iris pigment epithelial cells express their own B7-2 to achieve global suppression of T cell activation. | lld:pubmed |
pubmed-article:15034031 | pubmed:affiliation | Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, MA 02114, USA. | lld:pubmed |
pubmed-article:15034031 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15034031 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:15034031 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
entrez-gene:12477 | entrezgene:pubmed | pubmed-article:15034031 | lld:entrezgene |
entrez-gene:12487 | entrezgene:pubmed | pubmed-article:15034031 | lld:entrezgene |
entrez-gene:12519 | entrezgene:pubmed | pubmed-article:15034031 | lld:entrezgene |
entrez-gene:12524 | entrezgene:pubmed | pubmed-article:15034031 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:15034031 | lld:entrezgene |